Bone loss in SMART study
26 December 2008. Related: Conference reports, Side effects.
Conference reports
Parathyroid hormone and vitamin D levels in patients using tenofovir
26 December 2008. Related: Conference reports, Side effects.
Haemoglobin A1c (HbA1c) may underestimate glycaemia in patients with diabetes on HIV therapy
26 December 2008. Related: Conference reports, Side effects, Weight, diabetes, metabolic complications.
Statin use in HIV-positive patients
26 December 2008. Related: Conference reports, Side effects, Weight, diabetes, metabolic complications.
HIV reinfection reported in 10% of couples in Zambian study
26 December 2008. Related: Conference reports, HIV prevention and transmission.
Drug interaction studies with approved drugs
26 December 2008. Related: Conference reports, PK and drug interactions.
Non alcoholic fatty liver disease (NAFLD) is common among HIV-positive patients
26 December 2008. Related: Conference reports, Antiretrovirals.
17th International AIDS Conference, 3-8 August 2008, Mexico City
30 October 2008. Related: Conference reports.
Abacavir and heart disease: SMART study supports an abacavir-associated increased risk of cardiovascular disease
30 October 2008. Related: Conference reports, Antiretrovirals, Side effects.
HAART use in pregnancy and preterm delivery and low birth weight
30 October 2008. Related: Conference reports, Pregnancy.
Reasons for mother to child transmission in England
30 October 2008. Related: Conference reports, Pregnancy.
New paediatric formulations of ARVs
30 October 2008. Related: Conference reports, Paediatric care.
3rd International Transmission Workshop, 1-2 August 2008, Mexico City
30 October 2008. Related: Conference reports.
Intermittent tenofovir/FTC PrEP offers monkeys some protection
30 October 2008. Related: Conference reports, HIV prevention and transmission.
Tenofovir/FTC gel protects female monkeys from SHIV
30 October 2008. Related: Conference reports, HIV prevention and transmission.
Recently infected HIV-positive Quebec residents cause more than half of new cases
30 October 2008. Related: Conference reports, HIV prevention and transmission.
Common estimate of heterosexual HIV transmission risk sometimes far too low
30 October 2008. Related: Conference reports, HIV prevention and transmission.
10 key areas of research: non-technical summary of studies and presentations from Mexico
1 October 2008. Related: Special reports, Conference reports.
XVII International HIV Resistance Workshop (IHDRW), 6-10 June 2008, Sitges
30 August 2008. Related: Conference reports.
Integrase inhibitor resistance and cross-resistance: weighing viral fitness and the option to benefit from second-generation compounds
30 August 2008. Related: Conference reports, Drug resistance.
Understanding etravirine susceptibility: new weighted genotype score and phenotypic cut-offs
30 August 2008. Related: Conference reports, Drug resistance.
Pipeline antiretrovirals: IDX899, CHX157 and bevirimat
30 August 2008. Related: Conference reports, Antiretrovirals.
Lack of virological impact of treatment intensification in suppressed patients supports latent viral reservoir as source of residual viraemia
30 August 2008. Related: Conference reports, Drug resistance.
NNRTI resistance in infants prophylaxed with single-dose nevirapine varies by the timing of infection
30 August 2008. Related: Conference reports, Drug resistance.
Detecting viral tropism: impact of a more sensitive Trofile (ES) assay
30 August 2008. Related: Conference reports, Drug resistance.
Low frequency K103N mutations are associated with poor virological response to NNRTI based therapy
30 August 2008. Related: Conference reports, Drug resistance.
14th Annual BHIVA Conference, 23-25 April 2008, Belfast
30 August 2008. Related: Conference reports.
Bone problems raised in several UK studies
30 August 2008. Related: Conference reports, Side effects.
Late diagnosis in adolescence of vertically acquired HIV infection
30 August 2008. Related: Conference reports, Paediatric care.
Case study of multi-drug resistant woman receiving newer antiretroviral drugs in pregnancy
30 August 2008. Related: Conference reports, Pregnancy.
Predictors of treatment failure in Western Cape, South Africa
30 August 2008. Related: Conference reports.
Late pregnancy loss in HIV-positive women
30 August 2008. Related: Conference reports, Pregnancy.
Renal tubular dysfunction with tenofovir-based HAART in four vertically infected adolescents
30 August 2008. Related: Conference reports, Antiretrovirals.
15th Conference on Retroviruses and Opportunistic Infections, Boston, 2-6 February 2008
30 August 2008. Related: Conference reports.
The unmet need for contraception services for women receiving ART
30 August 2008. Related: Conference reports, Women's health.
Valacyclovir decreases plasma and genital viral loads in HSV-2/HIV-1 co-infected women
30 August 2008. Related: Conference reports, Women's health.
HPV genotypes in HIV-positive women in Zimbabwe and Uganda
30 August 2008. Related: Conference reports, Women's health.
14th Annual BHIVA Conference, 23-25 April 2008, Belfast
12 June 2008. Related: Conference reports.
Overview of MRC studies in 2008
12 June 2008. Related: Conference reports.
Initial results of BHIVA audit of HIV-related inpatient and day care in the UK
12 June 2008. Related: Conference reports.
Monitoring patients on antiretroviral therapy in resource-limited settings with viral load, CD4 count, or clinical observation alone
12 June 2008. Related: Conference reports.
Lower bilirubin increases in HCV-positive patients using atazanavir
12 June 2008. Related: Conference reports.
Cases of ventricular tachycardia and atazanavir/r and methadone
12 June 2008. Related: Conference reports.
Choice of ARVs for people after organ transplantation
12 June 2008. Related: Conference reports.
Use of fibroscan as non-invasive alternative to liver biopsy in HCV/HIV coinfection
12 June 2008. Related: Conference reports, Hepatitis coinfection.
New-fill used to treat lipoatropy in feet
12 June 2008. Related: Conference reports, Side effects, Weight, diabetes, metabolic complications.
Effect of 100mg ritonavir once- and twice-daily on lipids and cardiovascular markers in HIV-negative volunteers
12 June 2008. Related: Conference reports.
15th Conference on Retroviruses and Opportunistic Infections, Boston, 2-6 February 2008
12 June 2008. Related: Conference reports.
Immediate HAART reduces death and AIDS progression over 48 weeks in patients with acute OIs
12 June 2008. Related: Conference reports, Coinfections and complications.
Utility of routine viral load, CD4 count and clinical monitoring among HIV-positive adults in rural Uganda
12 June 2008. Related: Conference reports, Treatment access.
Implementation of more complex regimens for prevention of mother-to-child transmission of HIV in Rwanda
12 June 2008. Related: Conference reports, Treatment access.
The estimated cost of switching from d4T to TDF in South Africa
12 June 2008. Related: Conference reports, Treatment access.
Gender differences in viral load by CD4 count in men and women
12 June 2008. Related: Conference reports, Women's health.
Immune reconstitution inflammatory syndrome in young children initiating ART
12 June 2008. Related: Conference reports, Paediatric care.
Complications with BCG vaccination in HIV-positive and negative infants: CHER Study
12 June 2008. Related: Conference reports, Paediatric care.
The association between clinical characteristics and HIV-infection in very young infants
12 June 2008. Related: Conference reports, Paediatric care.
Safety and efficacy of boosted darunavir in treatment-experienced children and adolescents at 24 weeks
12 June 2008. Related: Conference reports, Paediatric care.
Responses to atazanavir-containing HAART in treatment-naive children in South Africa
12 June 2008. Related: Conference reports, Paediatric care.
Initial growth, CD4, and viral load responses to HAART in Ugandan compared to UK/Irish HIV-positive children
12 June 2008. Related: Conference reports, Paediatric care.
Paediatric pharmacokinetic studies
12 June 2008. Related: Conference reports, Paediatric care.
A pilot study of three treatment strategies for HIV-positive infants
12 June 2008. Related: Conference reports, Paediatric care.
15th Conference on Retroviruses and Opportunistic Infections, 2-6 February 2008, Boston
2 April 2008. Related: Conference reports.
Atazanavir/r vs lopinavir/r in treatment-naive patients: 48 week results
1 April 2008. Related: Conference reports, Antiretrovirals.
Baseline inflammation and coagulation markers and changes over four weeks during a treatment interruption are strongly linked to HIV viraemia and risk of mortality
1 April 2008. Related: Conference reports.
Restarting treatment after an interruption reduces the risk of serious events but CD4 recovery falls short of baseline levels
1 April 2008. Related: Conference reports.